Showing results (1471-1480 of 1,614) with videos related to

Sort By:
Pageof 162
RSC Medicinal Chemistry|January 30, 2026
CNS penetrant TEAD1,2,4 inhibitor MSC-4070 derived from phenotypic screening hit optimizationTimo Heinrich, Carl Petersson, Jakub Gunera, et al.
RSC Medicinal Chemistry|January 16, 2026
Revealing deamidation and isoaspartate formation during peptide analysis, purification and storage by tandem mass spectrometryV Erckes, L Chamera Rendueles, A Misiek, et al.
RSC Medicinal Chemistry|January 19, 2026
Strategies to inhibit steroid cytochrome P450 enzymes to benefit human health: development of steroid ligands for P450s 17A1, 19A1, and 8B1 to treat cancer and obesityTu M Ho, Francis K Yoshimoto
RSC Medicinal Chemistry|January 19, 2026
Ferrocenyl ferroptosis inducers as an emerging class of anticancer agents: a mini reviewMateusz Klarek, Aryan Gautam, Konrad Kowalski
RSC Medicinal Chemistry|January 15, 2026
From lab to environment: forecasting pharmaceutical impact using in silico and analytical toolsHamza Boucetta, Peije Russell, David Rudd, et al.
RSC Medicinal Chemistry|January 12, 2026
Discovery of novel polymyxin E adjuvants against Acinetobacter baumannii guided by a stacking-based machine learning modelYuce Chen, Kunkun Shen, Ting Lin, et al.
RSC Medicinal Chemistry|February 4, 2026
Oxyprenyl-chalcones as antibacterial hits: design of experiments-optimized synthesis, antibacterial evaluation, early drug-like profiling and biodegradability predictionLudovica Marotta, Francesca Maria Pia Rita Giammarino, Brondon Brandly Senenou Tambou, et al.
RSC Medicinal Chemistry|February 9, 2026
Synthesis and biological evaluation of carabrol derivativesHaidi Wu, Mengshi Zhao, Shifeng Ren, et al.
RSC Medicinal Chemistry|December 8, 2025
Novel pyrido[2,3-b][1,4]oxazine-based EGFR-TK inhibitors: rational design and synthesis of potent and selective agents targeting resistance mutations in non-small cell lung cancerVaibhav B Yadav, Shailee V Tiwari, S Hemant Kumar, et al.
RSC Medicinal Chemistry|December 12, 2025
Developing pyrazole-oxadiazole conjugates as potent anti-tubercular agents: an in silico and in vitro approachSethu Arun Kumar, Gurdayal Besra, Sarah Batt, et al.
Pageof 162